Olympus splits scientific solutions from medtech to create Evident subsidiary

Olympus (TYO: 7733) announced today that it has completed the separation of its Scientific Solutions Division into a wholly-owned subsidiary called Evident.

The creation of Evident — which encompasses life science research and industrial equipment — enables Olympus management to better focus on the continued growth of the company’s Medical Business, which made up 86% of revenue in the company’s 2020–21 fiscal year.

Headquartered in Japan, Evident will operate independently under the Olympus corporate umbrella. Olympus said the new Evident name exemplifies a commitment to providing high-quality products and technical expertise — and a renewed focus on customer collaboration and responsiveness to customer concerns.

“Evident, while continuing to provide best-in-class products, will expand its digital and cloud-based solutions to enhance the customer experience and to improve the overall workflow in the research and inspection fields,” said…

Read more
  • 0